I’m as skeptical as you are of GILD’s plans in cancer. GILD has too much cash for its own good and is getting sucked into investments that probably won’t produce a good return for shareholders.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”